Medical Doctor Program year 2020 Reported 2019–2020 Source: CMS Open Payments, 2026 publication

Paul Tornambe

Ophthalmology Poway, CA Medical Doctor

NPI 1700838208 CMS profile 213612

12630 Monte Vista Rd, Suite # 104, Poway, CA 92064

Open in the dashboard

General payments

$1,134

7 records reported · program years 2019–2020

Research payments

$0

Paid to them · None reported · program years 2019–2020

Ownership & investment interest

$5,000

1 holding reported · through program year 2020

Research they led as principal investigator

$9,295 paid to institutions, not to them · program year 2019

Through program year 2020, Paul Tornambe of Poway, CA is reported in the CMS Open Payments database as having received $1,134 across 7 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $9,295 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $5,000 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 47th percentile of Ophthalmology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2020 General $500 1
2019 General $634 6
2019 Ownership $5,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paul Tornambe
  • Ophthalmology median
  • Middle half of Ophthalmology
  • National median

In program year 2025, general payments to Paul Tornambe were reported at $0. Among 13,034 Ophthalmology profiles paid that year, the median was $384 and the middle half received between $136 and $917.

Show as a table
Year Paul Tornambe Ophthalmology median Middle half National median
2019 $634 $258 $104–$655 $163
2020 $500 $126 $45–$321 $114
2021 $0 $205 $76–$534 $132
2022 $0 $266 $100–$678 $149
2023 $0 $308 $117–$745 $160
2024 $0 $340 $127–$846 $164
2025 $0 $384 $136–$917 $169

Breakdown

Who paid General payments · program years 2019–2020
  1. Optovue, Inc. $510 2 payments
  2. US Retina LLC $379 1 payment
  3. Kala Pharmaceuticals, Inc. $125 1 payment
  4. Alcon Vision LLC $74 1 payment
  5. Novartis Pharmaceuticals Corporation $26 1 payment
  6. Allergan Inc. $20 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2020
  1. Gift $500 1 payment
  2. Current or prospective ownership or investment interest $379 1 payment
  3. Food and Beverage $255 5 payments
Products named General payments · program years 2019–2020
  1. XR $500 1 payment
  2. INVELTYS $125 1 payment
  3. Luxor $74 1 payment
  4. OZURDEX $20 1 payment
  5. iCam $10 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

7 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Ophthalmology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2020

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record